# The Optimal Dosage of Rocuronium for Intraoperative Neuromonitoring During Thyroid Surgery

> **NCT02377882** · — · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 80 (actual)

## Conditions studied

- THYROIDECTOMY

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02377882
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02377882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02377882, "The Optimal Dosage of Rocuronium for Intraoperative Neuromonitoring During Thyroid Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02377882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*